AMENDED AND RESTATED INTEREST AGREEMENTAmended and Restated Interest Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
This Amended and Restated Interest Agreement (this “Agreement”) is entered into on October 24, 2016 (the “Execution Date”), and made effective as of September 22, 2015 (the “Effective Date”), by and between LIGHTLAKE THERAPEUTICS INC., a Nevada corporation (the “Company”), and Valour Fund, LLC, a Delaware limited liability company and successor in interest to this Agreement (“Valour”).
AMENDED AND RESTATED INTEREST AGREEMENTAmended and Restated Interest Agreement • October 28th, 2016 • Opiant Pharmaceuticals, Inc. • Metal mining • Nevada
This Amended and Restated Interest Agreement (this “Agreement”) is entered into on October 24, 2016 (the “Execution Date”), and made effective as of July 22, 2014 (the “Effective Date”), by and between OPIANT PHARMACEUTICALS, INC., a Nevada corporation (the “Company”), and Valour Fund, LLC, a Delaware limited liability company and successor in interest to this Agreement (“Valour”).
